http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2665037-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9da697a707797292414f479a92f686ff |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6541 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6541 |
| filingDate | 2016-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff1840b48e558c077df7ab474e44ff7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e76fd828d6017813783366caed710e2 |
| publicationDate | 2018-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2665037-C2 |
| titleOfInvention | Isopropyl n-[{[(1r)-2-(6-amino-9h-purin-9-il)-1-methyletoxy]methyl} (1,3-benzotiazol-6-il-oxy)phosphoryl]-l-alaninate fumarat as an antiviral drug - prodrug of tenofovir |
| abstract | FIELD: chemistry. n SUBSTANCE: invention relates to isopropyl N-[{[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}(1,3-benzothiazol-6-yl-oxy)phosphoryl]-L-alaninate fumarate of formula 1. n n n n EFFECT: compound of the invention has antiviral properties with respect to hepatitis B viruses and is intended for the treatment of viral hepatitis B. n 5 cl, 2 tbl, 2 ex |
| priorityDate | 2016-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 164.